Suppr超能文献

源自:美国心脏协会关于预防草绿色链球菌感染性心内膜炎的科学声明。

Adapted from: Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association.

出版信息

J Am Dent Assoc. 2021 Nov;152(11):886-902.e2. doi: 10.1016/j.adaj.2021.09.003.

Abstract

BACKGROUND

In 2007, the American Heart Association published updated evidence-based guidelines on the recommended use of antibiotic prophylaxis to prevent viridans group streptococcal (VGS) infective endocarditis (IE) in cardiac patients undergoing invasive procedures. The 2007 guidelines significantly scaled back the underlying conditions for which antibiotic prophylaxis was recommended, leaving only 4 categories thought to confer the highest risk of adverse outcome. The purpose of this update is to examine interval evidence of the acceptance and impact of the 2007 recommendations on VGS IE and, if needed, to make revisions based on this evidence.

METHODS AND RESULTS

A writing group was formed consisting of experts in prevention and treatment of infective endocarditis including members of the American Dental Association, the Infectious Diseases Society of America, and the American Academy of Pediatrics, in addition to the American Heart Association. MEDLINE database searches were done for English language articles on compliance with the recommendations in the 2007 guidelines and the frequency of and morbidity or mortality from VGS IE after publication of the 2007 guidelines. Overall, there was good general awareness of the 2007 guidelines but variable compliance with recommendations. There was no convincing evidence that VGS IE frequency, morbidity, or mortality has increased since 2007.

CONCLUSIONS

On the basis of a review of the available evidence, there are no recommended changes to the 2007 VGS IE prevention guidelines. We continue to recommend VGS IE prophylaxis only for categories of patients at highest risk for adverse outcome while emphasizing the critical role of good oral health and regular access to dental care for all. Randomized controlled studies to determine whether antibiotic prophylaxis is effective against VGS IE are needed to further refine recommendations.

摘要

背景

2007 年,美国心脏协会发布了更新的循证指南,建议使用抗生素预防来预防侵袭性操作的心脏患者发生草绿色链球菌(VGS)感染性心内膜炎(IE)。2007 年的指南大大缩小了推荐使用抗生素预防的基础条件,只保留了 4 类被认为具有最高不良后果风险的情况。本次更新的目的是检查 2007 年建议对 VGS IE 的接受程度和影响的间隔证据,如果有必要,根据这些证据进行修订。

方法和结果

成立了一个由预防和治疗感染性心内膜炎的专家组成的写作小组,包括美国牙科协会、美国传染病学会和美国儿科学会的成员,以及美国心脏协会。进行了 MEDLINE 数据库检索,以查找关于 2007 年指南建议的遵守情况的英语文章,以及 2007 年指南发布后 VGS IE 的频率以及发病率或死亡率。总体而言,人们对 2007 年指南有较好的普遍认识,但对建议的遵守情况各不相同。没有令人信服的证据表明自 2007 年以来 VGS IE 的频率、发病率或死亡率有所增加。

结论

根据对现有证据的审查,不需要对 2007 年 VGS IE 预防指南进行推荐更改。我们继续仅推荐对处于最高不良后果风险的患者类别进行 VGS IE 预防,同时强调所有患者保持良好口腔健康和定期获得牙科护理的关键作用。需要进行随机对照研究来确定抗生素预防是否对 VGS IE 有效,以进一步完善建议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验